Aspacytarabine (Bst-236) Is Safe And Efficacious As A Single-Agent, First-Line Therapy For Patients With Acute Myeloid Leukemia Unfit For Standard Chemotherapy. Integrated Results From A Phase 1/2a And An Ongoing Phase 2b
BLOOD(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要